Frequency of K-ras Mutations in Pancreatic Intraductal Neoplasias Associated with Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis: A Meta-Analysis

Löhr, Matthias, Klöppel, Gunter, Maisonneuve, Patrick, Lowenfels, Albert B., Lüttges, Jutta·2005·Neoplasia

Cited by (346)

Items 101–200 of 346

  1. Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview
    Nilabja Sikdar, Gourab Saha, Ashmita Dutta, Shibajyoti Ghosh, Shailesh Vinayak Shrikhande, Sudeep Banerjee · 2018 · Current Genomics
  2. Pancreatic intraepithelial neoplasia – can we detect early pancreatic cancer?
    Beate Haugk · 2010 · Histopathology
  3. KRAS Engages AGO2 to Enhance Cellular Transformation
    Sunita Shankar, Sethuramasundaram Pitchiaya, Rohit Malik, Vishal Kothari, Yasuyuki Hosono, Anastasia K. Yocum, Harika Gundlapalli, Yasmine N. White, Ari J. Firestone, Xuhong Cao et al. · 2016 · Cell Reports
  4. A Novel Combinatorial Nanotechnology-Based Oral Chemopreventive Regimen Demonstrates Significant Suppression of Pancreatic Cancer Neoplastic Lesions
    B. Karthik Grandhi, Arvind D. Thakkar, Jeffrey Wang, Sunil V. Prabhu · 2013 · Cancer Prevention Research
  5. The Multifaceted Role of miR-21 in Pancreatic Cancers
    Clare Chen, Lusine H. Demirkhanyan, Christopher S. Gondi · 2024 · Cells
  6. Detection of KRAS Gene Mutations in Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsy for Improving Pancreatic Cancer Diagnosis
    Xiaowei Wang, Jun Gao, Yan Ren, Junjun Gu, Yiqi Du, Jie Chen, Zhendong Jin, Xianbao Zhan, Zhaoshen Li, Haojie Huang et al. · 2011 · The American Journal of Gastroenterology
  7. Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib
    Ganji Purnachandra Nagaraju, Anya I. Mezina, Walid Labib Shaib, Jerome Carl Landry, Bassel F. El‐Rayes · 2015 · European Journal of Cancer
  8. Pre-Operative Imaging and Pathological Diagnosis of Localized High-Grade Pancreatic Intra-Epithelial Neoplasia without Invasive Carcinoma
    Ryota Sagami, Kentaro Yamao, Jun Nakahodo, Ryuki Minami, Masakatsu Tsurusaki, Kazunari Murakami, Yuji Amano · 2021 · Cancers
  9. Advanced imaging techniques for chronic pancreatitis
    Anushri Parakh, Temel Tirkes · 2019 · Abdominal Radiology
  10. Understanding the stroma of pancreatic cancer: co‐evolution of the microenvironment with epithelial carcinogenesis
    Mert Erkan · 2013 · The Journal of Pathology
  11. HER2/neu expression and gene alterations in pancreatic ductal adenocarcinoma: a comparative immunohistochemistry and chromogenic in situ hybridization study based on tissue microarrays and computerized image analysis.
    Evangelos Tsiambas, Andreas Karameris, Christos Dervenis, Andreas Ch Lazaris, Niki Giannakou, Kyriakos Gerontopoulos, Efstratios Patsouris · 2006 · PubMed
  12. Molecular markers in pancreatic cancer diagnosis
    Marta Herreros‐Villanueva, Meritxell Gironella, Antoni Castells, Luís Bujanda · 2013 · Clinica Chimica Acta
  13. Lkb1 regulates organogenesis and early oncogenesis along AMPK-dependent and -independent pathways
    Bryan Lo, Geraldine A. Strasser, Meredith S. Sagolla, Cary D. Austin, Melissa R. Junttila, Ira Mellman · 2012 · The Journal of Cell Biology
  14. New farnesyltransferase inhibitors in the phenothiazine series
    Dalila Belei, Carmen Dumea, Alexandrina Samson, Amaury Farce, Joëlle Dubois, Elena Bîcu, Alina Ghinet · 2012 · Bioorganic & Medicinal Chemistry Letters
  15. Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma
    Chen Liang, Yi Qin, Bo Zhang, Shunrong Ji, Si Shi, Wenyan Xu, Jiang Liu, Jinfeng Xiang, Dingkong Liang, Qiangsheng Hu et al. · 2016 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  16. Cells of origin of pancreatic neoplasms
    Junpei Yamaguchi, Yukihiro Yokoyama, Toshio Kokuryo, Tomoki Ebata, Masato Nagino · 2017 · Surgery Today
  17. Chronic pancreatitis of alcoholic and nonalcoholic origin
    Günter Klöppel · 2004 · Seminars in Diagnostic Pathology
  18. Recent advances in targeted therapy for pancreatic adenocarcinoma
    Yuting Fang, Wenwei Yang, Yaru Niu, Yongkun Sun · 2023 · World Journal of Gastrointestinal Oncology
  19. Biological characteristics of pancreatic ductal adenocarcinoma: Initiation to malignancy, intracellular to extracellular
    Ou Li, Li Li, Yunru Sheng, Kun Ke, Jianzhang Wu, Yiping Mou, Mingyang Liu, Weiwei Jin · 2023 · Cancer Letters
  20. Endoscopic ultrasound in chronic pancreatitis: Where are we now?
    Andrada Seicean · 2010 · World Journal of Gastroenterology
  21. Update on pancreatic cancer and alcohol‐associated risk
    Thilo Welsch, Jorg H. Kleeff, Helmut Karl Seitz, Peter Büchler, Helmut Friess, Markus Wolfgang Büchler · 2006 · Journal of Gastroenterology and Hepatology
  22. Exosomal long non-coding RNAs in the diagnosis and oncogenesis of pancreatic cancer
    Eunice Eugenia Robless, Justin Andrew Howard, Ilaria Casari, Marco Falasca · 2020 · Cancer Letters
  23. Self-nanoemulsifying drug delivery system for pancreatic cancer
    Neha Parveen, Afsana Sheikh, Mohammed A. S. Abourehab, Ritu Karwasra, Surender Singh, Prashant Kesharwani · 2023 · European Polymer Journal
  24. Modifiable and Non-Modifiable Risk Factors for the Development of Non-Hereditary Pancreatic Cancer
    Marek Olakowski, Łukasz Bułdak · 2022 · Medicina
  25. The HMGA1-COX-2 axis: A key molecular pathway and potential target in pancreatic adenocarcinoma
    Jöelle Hillion, Shamayra S. Smail, Francescopaolo Di Cello, Amy Belton, Sandeep N. Shah, Tait H Huso, Andrew Schuldenfrei, Dwella M. Nelson, Leslie Cope, Nathaniel R. Campbell et al. · 2012 · Pancreatology
  26. Requirement of NEMO/IKKγ for effective expansion of KRAS-induced precancerous lesions in the pancreas
    Harald J. Maier, M Wagner, Tobias G. Schips, Heba Hamed Salem, Bernd Baumann, Thomas Christian Wirth · 2012 · Oncogene
  27. Histologic characteristics of pancreatic intraepithelial neoplasia associated with different pancreatic lesions
    Claudia Recavarren, Daniel M. Labow, John J. Liang, Lanjing Zhang, Melisa Wong, Hongfa Zhu, Jinhua Wang, Franto Francis, Ruliang Xu · 2010 · Human Pathology
  28. Metabolic Syndrome Components and Risk Factors for Pancreatic Adenocarcinoma: A Case-Control Study in China
    Qiao Wu, Ge Chen, Wenming Wu, Li Zhou, Lei You, Taiping Zhang, Yu-pei Zhao · 2012 · Digestion
  29. The Role of Next-Generation Sequencing in the Cytologic Diagnosis of Pancreatic Lesions
    Dario de Biase, Michela Visani, Giorgia Acquaviva, Adele Fornelli, Michele Masetti, Carlo Fabbri, Annalisa Pession, Giovanni Tallini · 2018 · Archives of Pathology & Laboratory Medicine
  30. Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overview
    Kanan Panchal, Rakesh Kumar Sahoo, Umesh Dutta Gupta, Akash Chaurasiya · 2021 · International Immunopharmacology
  31. The Microbiome as a Potential Target for Therapeutic Manipulation in Pancreatic Cancer
    Rozana Abdul Rahman, Ángela Lamarca, Richard A Hubner, Juan W. Valle, Mairead Geraldine McNamara · 2021 · Cancers
  32. Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma
    Ann Mary Joseph, Ahmad Al Aiyan, Basel K. al-Ramadi, Shiv K. Singh, Uday Kishore · 2024 · Frontiers in Immunology
  33. Molecular analysis of pancreatic acinar cell cystadenomas: Evidence of a non-neoplastic nature
    Frank Bergmann, Sebastian Aulmann, Thilo Welsch, Esther Herpel, Jens Martin Werner, Peter Schirmacher, Hendrik Bläker · 2014 · Oncology Letters
  34. Pancreatic Ductal Adenocarcinoma: Cellular Origin, Signaling Pathways and Stroma Contribution
    Inmaculada Hernńdez-Muñoz, Anouchka Skoudy, Francisco X. Real, Pilar Navarro · 2008 · Pancreatology
  35. Seed-in-Soil: Pancreatic Cancer Influenced by Tumor Microenvironment
    Huey-Jen L. Lin, Jiayuh Lin · 2017 · Cancers
  36. Homoharringtonine could induce quick protein synthesis of PSMD11 through activating MEK1/ERK1/2 signaling pathway in pancreatic cancer cells
    Lele Wang, Linlin Zhao, Wei Guo, Dieter Saur, Barbara Seidler, Junyan Wang, Chuanxin Wang, Tonggang Qi · 2018 · Journal of Cellular Biochemistry
  37. Diabetes mellitus, other medical conditions and pancreatic cancer: a case‐control study
    Loren P. Lipworth, Antonella Zucchetto, Cristina Bosetti, Silvia Franceschi, Renato Talamini, Diego Serraino, Joseph K. McLaughlin, Carlo La Vecchia, Eva Negri · 2010 · Diabetes/Metabolism Research and Reviews
  38. K-ras mutation analysis of residual liquid-based cytology specimens from endoscopic ultrasound-guided fine needle aspiration improves cell block diagnosis of pancreatic ductal adenocarcinoma
    Yoko Sekita‐Hatakeyama, Takeshi Nishikawa, Mao Takeuchi, Kouhei Morita, Maiko Takeda, Kinta Hatakeyama, Tokiko Nakai, Tomoko Uchiyama, Hiroe Itami, Tomomi Fujii et al. · 2018 · PLoS ONE
  39. Reporting precursors to invasive pancreatic cancer: pancreatic intraepithelial neoplasia, intraductal neoplasms and mucinous cystic neoplasm
    Roeland F. de Wilde, Ralph H. Hruban, Anirban Maitra, G. Johan A. Offerhaus · 2011 · Diagnostic histopathology
  40. Genomic Instability at Both the Base Pair Level and the Chromosomal Level Is Detectable in Earliest PanIN Lesions in Tissues of Chronic Pancreatitis
    Mario Baumgart, Meike Werther, Anke Bockholt, Maria Scheurer, Josef Rüschoff, Wolfgang Dietmaier, Β. Michael Ghadimi, Ernst Heinmöller · 2010 · Pancreas
  41. Pancreatic Intraepithelial Neoplasia
    Toby C. Cornish, Ralph H. Hruban · 2011 · Surgical pathology clinics
  42. Small-molecule inhibitors of the human epidermal receptor family
    Corey Allan Carter, Ronan Joseph Kelly, Giuseppe Giaccone · 2009 · Expert Opinion on Investigational Drugs
  43. Genomic alterations in pancreatic cancer and their relevance to therapy
    Erina Takai, Shinichi Yachida · 2015 · World Journal of Gastrointestinal Oncology
  44. Superoxide Dismutases in Pancreatic Cancer
    Justin G. Wilkes, Matthew S. Alexander, Joseph J. Cullen · 2017 · Antioxidants
  45. Molecular alterations in pancreatic tumors
    Michela Visani, Giorgia Acquaviva, Antonio De Leo, Viviana Sanza, Lidia Merlo, Thais Maloberti, Alba Ariela Brandes, Enrico Franceschi, Monica Di Battista, Michele Masetti et al. · 2021 · World Journal of Gastroenterology
  46. Chronic pancreatitis and cancer risk in a matched cohort study using national claims data in South Korea
    Minji Han, Thi Phuong Thao Tran, Jin‐Kyoung Oh · 2022 · Scientific Reports
  47. Mutant-Enriched PCR and Allele-Specific Hybridization Reaction to Detect K-ras Mutations in Stool DNA: High Prevalence in a Large Sample of Older Adults
    Ulrike Haug, Timo Hillebrand, Peter Bendzkô, Michael Löw, Dietrich Rothenbacher, Christa Stegmaier, Hermann Brenner · 2007 · Clinical Chemistry
  48. Critical role of laser microdissection for genetic, epigenetic and proteomic analyses in pancreatic cancer
    Niccola Funel, Elisa Giovannetti, Luca Emanuele Pollina, Marco Del Chiaro, Franco Mosca, Ugo Boggi, Daniela Campani · 2011 · Expert Review of Molecular Diagnostics
  49. Insulin promotes invasion and migration of KRASG12D mutant HPNE cells by upregulating MMP‐2 gelatinolytic activity via ERK‐ and PI3K‐dependent signalling
    Guangfu Wang, Lingdi Yin, Yunpeng Peng, Yong Gao, Hao Gao, Jingjing Zhang, Nan Lv, Yi Miao, Zipeng Lu · 2019 · Cell Proliferation
  50. The role of pancreatic stellate cells in pancreatic cancer
    Mert Erkan · 2013 · Pancreatology
  51. Zeb1 in Stromal Myofibroblasts Promotes Kras -Driven Development of Pancreatic Cancer
    Irene Sangrador, Xavier Molero, Fiona Campbell, Sebastià Franch‐Expósito, Maria Rovira-Rigau, Esther Samper, Manuel Domínguez-Fraile, Cristina Fillat, Antoni Castells, Eva Cristina Vaquero · 2018 · Cancer Research
  52. BRAF-Driven Pancreatic Cancer: Prevalence, Molecular Features, and Therapeutic Opportunities
    Aaron Ciner, Yixing Jiang, Petr Frantisek Hausner · 2022 · Molecular Cancer Research
  53. The TGF-β superfamily as potential therapeutic targets in pancreatic cancer
    Rachel R. Tindall, Jennifer M. Bailey, Yanna Cao, Tien C. Ko · 2024 · Frontiers in Oncology
  54. Preventive effects of fermented brown rice and rice bran against N-nitrosobis (2-oxopropyl) amine-induced pancreatic tumorigenesis in male hamsters
    Toshiya Kuno, Satoru Takahashi, Hiroyuki Tomita, Kenji Hisamatsu, Akira Hara, Akihiro Hirata, Hiroshi Kobayashi, Hideki Mori · 2015 · Oncology Letters
  55. Variant Profiling of Candidate Genes in Pancreatic Ductal Adenocarcinoma
    Jiaqi Huang, Matthias J. Löhr, Magnus H. L. NILSSON, Ralf Segersvärd, Hans Matsson, Caroline Sophie Verbeke, Rainer Lothar Heuchel, Juha Kere, Anthony John Iafrate, Zongli Zheng et al. · 2015 · Clinical Chemistry
  56. Pancreatic Cancer: Recent Advances in Nanoformulation-Based Therapies
    Preshita Prafulla Desai, David Kong Ann, Jeffrey Wang, Sunil V. Prabhu · 2018 · Critical Reviews in Therapeutic Drug Carrier Systems
  57. Screening for Pancreatic Cancer
    Katherine E. Poruk, Matthew A. Firpo, Sean J. Mulvihill · 2014 · Advances in Surgery
  58. Intercellular TIMP-1-CD63 signaling directs the evolution of immune escape and metastasis in KRAS-mutated pancreatic cancer cells
    Chuan Wang, Ya‐Chin Hou, Yi‐Kai Hong, † Y.-H. Tai, Chieh Shen, Pei‐Chi Hou, Jhao-Lin Fu, Cheng-Lin Wu, Siao Muk Cheng, Daw‐Yang Hwang et al. · 2025 · Molecular Cancer
  59. Can Endoscopic Ultrasound Predict Pancreatic Intraepithelial Neoplasia Lesions in Chronic Pancreatitis?
    Julia Kim LeBlanc, Jey-Hsin Chen, Mohammad Al‐Haddad, Letícia P. Luz, Lee McHenry, Stuart Sherman, Michelle R. Juan, John M. DeWitt · 2014 · Pancreas
  60. Monoclonal Antibodies and Other Targeted Therapies for Pancreatic Cancer
    Pelin Cinar, Margaret A. Tempero · 2012 · The Cancer Journal
  61. Decoding the Intricate Landscape of Pancreatic Cancer: Insights into Tumor Biology, Microenvironment, and Therapeutic Interventions
    Antonella Argentiero, Alessandro Andriano, Ingrid Catalina Caradonna, Giulia De Martino, Vanessa Desantis · 2024 · Cancers
  62. Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment
    Mary Linton B. Peters, Jennifer F. Tseng, Rebecca Anne Miksad · 2016 · Clinical Therapeutics
  63. MicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression
    Run-Fen Cheng, Jian Wang, Jing-Yi Zhang, Lin Sun, Yan Zhao, Zhi Qiu, Bao Sun, Yan Sun · 2016 · 癌症:英文版
  64. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling
    James Randolph Sanders Hocker, Russell G. Postier, Min Li, Megan R. Lerner, Stan A. Lightfoot, Marvin D. Peyton, Subrato J. Deb, Candace M Baker, Travis L. Williams, Rushie J. Hanas et al. · 2015 · Cancer Letters
  65. Intraductal papillary mucinous neoplasms of the pancreas: Clinical association with KRAS
    Xiaoyan Chang, Yan Wu, Yuan Li, Jing Wang, Jie Chen · 2018 · Molecular Medicine Reports
  66. Evaluating Pancreatic and Biliary Neoplasms with Small Biopsy-Based Next Generation Sequencing (NGS): Doing More with Less
    Ilias P. Nikas, Giannis Mountzios, Guy I. Sydney, Kalliopi J. Ioakim, Jae‐Kyung Won, Panagiotis Papageorgis · 2022 · Cancers
  67. C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling Overall Survival Prediction in Pancreatic Cancer Patients
    Konstantin Schlick, Teresa Magnes, Florian Huemer, Lukas Ratzinger, Lukas Weiß, Martin Pichler, Thomas Melchardt, Richard Greil, Alexander Egle · 2019 · Journal of Clinical Medicine
  68. Mutational spectrum of intraepithelial neoplasia in pancreatic heterotopia
    Changqing Ma, Christopher D. Gocke, Ralph H. Hruban, Deborah Belchis · 2015 · Human Pathology
  69. Differing molecular pathology of pancreatic adenocarcinoma in Egyptian and United States patients
    Amr S. Soliman, Melissa L. Bondy, C. Renee Webb, David Schottenfeld, Joseph D. Bonner, Nabih El‐Ghawalby, Ahmed Soultan, Mohamed Abdel Wahab, Omar M. Fathy, Gamal El Ebidy et al. · 2006 · International Journal of Cancer
  70. New Advances in the Treatment of Metastatic Pancreatic Cancer
    Marvin Schober, Muhammad Ahsan Javed, Georg Beyer, Nha Ngoc Hoa Le, Alessio Vinci, Malin Sund, Albrecht Neeße, Sebastian Krug · 2015 · Digestion
  71. Mucoepidermoid carcinoma (MEC) and adenosquamous carcinoma (ASC), the same or different entities?
    Valerie Ann White, Martin D. Hyrcza, Jochen K. Lennerz, Julia Thierauf, Dilani Lokuhetty, Ian A. Cree, Blanca Iciar Indave · 2022 · Modern Pathology
  72. Molecular Genetics of Pancreatic Neoplasms
    Waki Hosoda, Laura DeLong Wood · 2016 · Surgical pathology clinics
  73. Satellite RNA Increases DNA Damage and Accelerates Tumor Formation in Mouse Models of Pancreatic Cancer
    Takahiro Kishikawa, Motoyuki Otsuka, Tatsunori Suzuki, Takahiro Seimiya, Kazuma Sekiba, Rei Ishibashi, Eri Tanaka, Motoko Ohno, Mari Yamagami, Kazuhiko Koike · 2018 · Molecular Cancer Research
  74. Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single‐cell analysis
    Sooin Byeon, Taymin du Toit‐Thompson, Josef Gillson, Anthony James Gill, Jaswinder Singh Samra, Anubhav Mittal, Sumit Sahni · 2023 · Cancer Medicine
  75. A case of MUC5AC-positive intraductal neoplasm of the pancreas classified as an intraductal tubulopapillary neoplasm?
    Takashi Muraki, Takeshi Uehara, Kenji Sano, Hiroyoshi Oota, Akihiko Yoshizawa, Shiho Asaka, Ayako Tateishi, Toshiaki Otsuki, Kunihiko Shingu, Hisanori Matoba et al. · 2015 · Pathology - Research and Practice
  76. Molecular Alterations in Exocrine Neoplasms of the Pancreas
    Prathibha Ranganathan, Harsha Gowda, Akhilesh Pandey · 2009 · Archives of Pathology & Laboratory Medicine
  77. Pan-KRAS inhibitors suppress proliferation through feedback regulation in pancreatic ductal adenocarcinoma
    Cheng-xiang Wang, Tingting Wang, Kun-Dong Zhang, Mingyu Li, Qiancheng Shen, Shaoyong Lu, Jian Zhang · 2022 · Acta Pharmacologica Sinica
  78. Nanoparticle albumin-bound (nab)-paclitaxel for the treatment of pancreas ductal adenocarcinoma
    Colin D. Weekes, Vignesh Narayanan · 2015 · Gastrointestinal Cancer Targets and Therapy
  79. Ciblage de la voie de signalisation RAS pour le traitement des cancers
    Laura Mansi, Erika Viel, Elsa Curtit, Jacques Médioni, Christophe Le Tourneau · 2011 · Bulletin du Cancer
  80. Involvement of inflammatory factors in pancreatic carcinogenesis and preventive effects of anti-inflammatory agents
    Mami Takahashi, Michihiro Mutoh, Rikako Ishigamori, Gen Fujii, Toshio Imai · 2012 · Seminars in Immunopathology
  81. PANDA cyst-fluid analysis: eats, shoots and leaves?
    Michelle Ann Anderson, Richard S. Kwon, James M. Scheiman · 2009 · Gastrointestinal Endoscopy
  82. Prognostic value of KRAS subtype in patients with PDAC undergoing radical resection
    Manxiong Dai, Raja Jahanzaib, Yan Liao, Fengxuan Yao, Jia Li, Xiong Teng, Kang Chen, Wei Cheng · 2022 · Frontiers in Oncology
  83. Current Molecular and Genetic Aspects of Pancreatic Cancer, the Role of Metastasis Associated Proteins (MTA): A Review
    T. Pavlidis, T. Pavlidis · 2017 · Journal of Investigative Surgery
  84. Peptide chemistry applied to a new family of phenothiazine-containing inhibitors of human farnesyltransferase
    Gina‐Mirabela Dumitriu, Alina Ghinet, Elena Bîcu, Benoı̂t Rigo, Joëlle Dubois, Amaury Farce, Dalila Belei · 2014 · Bioorganic & Medicinal Chemistry Letters
  85. Differences in K-ras and p53 gene mutations among pancreatic adenocarcinomas associated with regional environmental pollution
    Amr S. Soliman, An‐Chi Lo, Mousumi Banerjee, N el-Ghawalby, Hussein Moustafa Khaled, S. Bayoumi, Ibrahim A. Seifeldin, Ahmed Abdelaziz, James L. Abbruzzese, Joel K. Greenson et al. · 2007 · Carcinogenesis
  86. Genetic Signature of Human Pancreatic Cancer and Personalized Targeting
    Stephan J. Reshkin, Rosa Angela Cardone, Tomas Koltai · 2024 · Cells
  87. Genetic alterations in precancerous pancreatic lesions and their clinical implications
    Olivıer Turrini, Carla Eliana Cano, A. Legoffic, Jean‐Robert Delpéro, Jean–Charles Dagorn, Juan Iovanna · 2009 · Gastroentérologie Clinique et Biologique
  88. Harnessing the Microbiome to Reduce Pancreatic Cancer Burden
    Ana Raquel Bastos, Joana Pereira‐Marques, Rui M. Ferreira, Céu Figueiredo · 2023 · Cancers
  89. Molecular mechanisms of pancreatic cancer and potential targets of treatment
    Ursula Aho, Xia Zhao, Matthias J. Löhr, Roland E. Andersson · 2007 · Scandinavian Journal of Gastroenterology
  90. Inhibition of mutant KrasG12D -initiated murine pancreatic carcinoma growth by a dual c-Raf and soluble epoxide hydrolase inhibitor t -CUPM
    Jie Liao, Sung Hee Hwang, Haonan Li, Yihe Yang, Jun Yang, Aaron T. Wecksler, Jun‐Yan Liu, Bruce D. Hammock, Guang‐Yu Yang · 2015 · Cancer Letters
  91. Crosstalk between miRNAs and signaling pathways involved in pancreatic cancer and pancreatic ductal adenocarcinoma
    Ziba Lotfi, Shiva Najjary, Fariba Lotfi, Mohammad Ali Amini, Amir Baghbanzadeh, Darya Javad Rashid, Elmira Roshani Asl, Behzad Baradaran, Ahad Mokhtarzadeh · 2021 · European Journal of Pharmacology
  92. Synthesis and biological evaluation of a new series of N-ylides as protein farnesyltransferase inhibitors
    Cristina‐Maria Abuhaie, Alina Ghinet, Amaury Farce, Joëlle Dubois, Benoı̂t Rigo, Elena Bîcu · 2013 · Bioorganic & Medicinal Chemistry Letters
  93. Progression of Chronic Pancreatitis to Pancreatic Cancer
    Sumaira Rashid, Nidhi Singh, Surabhi Gupta, Safoora Rashid, Nandini Nalika, Vikas Sachdev, Chandra Sekhar Bal, Siddhartha Datta Gupta, Shyam Singh Chauhan, Anoop Saraya · 2018 · Pancreas
  94. Current topics on precursors to pancreatic cancer.
    Kyoichi Takaori, Ralph H. Hruban, Anirban Maitra, N Tanigawa · 2006 · PubMed
  95. Pathology of Chronic Pancreatitis
    Giuseppe Zamboni, Paola Capelli, Günter Klöppel · 2009 · Medical radiology
  96. Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential
    Emilia Alors‐Pérez, Sergio Pedraza‐Arévalo, Ricardo Blázquez‐Encinas, María Trinidad Moreno-Montilla, Víctor García‐Vioque, Inmaculada Berbel, Raul Miguel Luque, Bruno Sáinz, Alejandro Ibáñez‐Costa, Justo Pastor Castano · 2023 · Journal of Experimental & Clinical Cancer Research
  97. Identification and analysis of pancreatic intraepithelial neoplasia: opportunities and challenges
    Ling-ling Pian, Mei-hui Song, Tengfei Wang, Ling Qi, Tie-li Peng, Ke-ping Xie · 2025 · Frontiers in Endocrinology
  98. Antitumor activity of erlotinib in combination with gemcitabine in in vitro and in vivo models of KRAS-mutated pancreatic cancers
    Koh Furugaki, TOSHIKI IWAI, Kumiko Kondoh, Yoichiro Moriya, Kazushige Mori · 2010 · Oncology Letters
  99. Phase I/II Clinical Trial of Encapsulated, Cytochrome P450 Expressing Cells as Local Activators of Cyclophosphamide to Treat Spontaneous Canine Tumours
    Monika Michałowska, S. Winiarczyk, Łukasz Adaszek, Wojciech Łopuszyński, Zbigniew Grądzki, Brian Salmons, Walter H. Günzburg · 2014 · PLoS ONE
  100. Giessen international workshop on interactions of exocrine and endocrine pancreatic diseases. Castle of Rauischholzhausen of the Justus-Liebig-University, Giessen, Germany. March 18-19, 2005.
    Åke Andrén‐Sandberg, Philip Daniel Hardt · 2005 · PubMed